|
Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?
|
Feb 2012
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
|
Dec 2014
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Assessing Quality of Care for the Myelodysplastic Syndromes
|
Aug 2016
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
|
Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria
|
Dec 2015
|
Am J Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia
|
Feb 2015
|
JAMA
|
aplastic anemia
|
|
Association between Transfusion Status and Overall Survival in Patients with Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis
|
Apr 2016
|
Acta Haematol
|
myelodysplastic syndromes (MDS)
|
|
Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents
|
Oct 2019
|
Leukemia & Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
Feb 2017
|
JAMA Oncol
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
Feb 2017
|
JAMA Oncol
|
|
|
Asthma and risk of myelodysplastic syndromes: a population-based cohort study
|
Nov 2016
|
Br J Cancer
|
myelodysplastic syndromes (MDS)
|
